After having recruited over 700 CRASH-4 participants, we are delighted to announce that CRASH-4 has been recommended for funding by the NIHR-HTA programme!
With over three hundred and fifty patients recruited we can finally look at the (blinded) trial data to see if we are recruiting the right group of patients.
